Live Breaking News & Updates on Covid suraksha

Stay informed with the latest breaking news from Covid suraksha on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covid suraksha and stay connected to the pulse of your community

Indian scientists welcome Nobel Prize for medicine, say mRNA vaccines can be developed for TB, dengue, other diseases

Dr Vinod Paul, member, the National Institution for Transforming India (NITI Aayog),said the mRNA pathway for vaccines has opened new doors.

India , Vinod-paul , Sanjay-singh , National-institution-for-transforming-india , Pune-based-gennova-biopharmaceuticals , National-institution , Transforming-india , Covid-suraksha , Nobel-prize-news , Obel-prize-in-medicine , Reation-of-covid-vaccines , Rna-vaccines-against-covid-19m

Scientists stress on use of advanced technology for multidisciplinary research in life sciences

At a three-day special training programme at Institute of Life Sciences (ILS), senior scientist Dr Sunil Raghav spoke about the significance of application-oriented basic research in life science.

Bhubaneswar , Orissa , India , Biswajit-mohanty , Sanghamitra-pati , Sunil-raghav , Institute-of-life-sciences , Biotechnology-industry-research-assistance-council , Jan-bhagidari-programme , Covid-suraksha-mission , News-service , Express-news

Explained: World's First Nasal Vaccine By Bharat Biotech And What We Know So Far

Explained: World's First Nasal Vaccine By Bharat Biotech And What We Know So Far
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

India , Hyderabad , Andhra-pradesh , Bharat , Krishna-ella , Maulana-azad-national-institute-of-technology , Department-of-biotechnology-covid-suraksha , Washington-university , Bharat-biotech , Republic-day , New-frontiers , Maulana-azad-national-institute

Operationalizing the One Health Approach: Nexus of Science, Indigenous Knowledge, Policy

Panelists: Chair: Dr. VK Paul, Hon'ble Member (Health), NITI Aayog • Dr. Richard Hatchett, CEO, CEPI, UK • Dr. Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb, USA • Ms. Cynthia McCaffrey, UNICEF Representative to India • Dr. Mahender Nayak, Head of Asia Pacific, Takeda Pharmaceuticals, Singapore •

United-states , Indonesia , India , United-kingdom , Singapore , Bharat , Kala-azar , Richard-hatchett , Covid-suraksha , Pashu-aadhar , Takeda-pharma , Mahender-nayak

India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose

The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.

India , Bharat , Mansukh-mandaviya , Jitendra-singh , Washington-university , Union-health , Department-of-biotechnology-covid-suraksha , Central-drugs-standard-control-organisation , India-gets-its-own-nasal-vaccine , Health-minister-dr-mansukh-mandaviya , Technology-minister-jitendra-singh , Bharat-biotech

Mansukh Mandaviya - Mansukh Mandaviya launches Bharat Biotech's nasal Covid vaccine iNCOVACC

The nasal vaccine -- BBV154 -- had received Drugs Controller General of India's approval in November for restricted emergency use among adults

India , Hyderabad , Andhra-pradesh , Bharat , Washington-university , Department-of-biotechnology-covid-suraksha , Drugs-controller-general , Bharat-biotech , Covid-suraksha ,

PM Modi's mother, 99, hospitalized in Gujarat, a day after her son meets with accident in Karnataka | coastaldigest.com

Heeraben Modi, who turned 99 in June this year, has been admitted to a hospital in Ahmedabad. A statement from UN Mehta Institute of Cardiology and Research Centre has said that her condition is stable. The hospital has not shared any other piece of information.

China , India , Hyderabad , Andhra-pradesh , New-delhi , Delhi , Bharat , Narendra-modi , Mansukh-mandaviya , Union-health , Union-health-ministry , Washington-university

Welcome To IANS Live - NATION - Bharat Biotech's intranasal Covid vaccine priced at Rs 800

The vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments, the Hyderabad-based company said.Last

India , Hyderabad , Andhra-pradesh , Bharat , Krishna-ella , Washington-university , Covid-suraksha-program , Technology-development-board , Ministry-of-health , Central-drugs-standard-control-organization , Department-of-biotechnology , Bharat-biotech

Nasal covid vaccine to cost Rs 800 at private hospitals, Rs 325 at govt ones

Bharat Biotech on Tuesday announced that its intranasal covid heterologous booster  iNCOVACC️ (BBV154) is scheduled to be introduced in the country in the fourth week of January and will cost Rs 800 privately and Rs 325 for large central and state government procurements.

Karnataka , India , Telangana , Andhra-pradesh , New-delhi , Delhi , Bharat , Krishna-ella , Aditi-tandon , Washington-university , Technology-development-board , Ministry-of-health

Bharat Biotech's intranasal Covid vaccine priced at Rs 800

The intranasal vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments,

India , Hyderabad , Andhra-pradesh , Bharat , Krishna-ella , Washington-university , Covid-suraksha-program , Technology-development-board , Ministry-of-health , Central-drugs-standard-control-organization , Department-of-biotechnology , Bharat-biotech